Basismedikamente

Basismedikamente is a term used in German-speaking health systems to refer to a predefined bundle of medicines considered essential for primary health care. The concept aligns with the World Health Organization’s essential medicines list and serves as a basis for procurement, prescribing, and reimbursement. Basismedikamente are typically generic, safe, effective, affordable, and suitable for common conditions seen in primary care, such as hypertension, diabetes, infections, pain, and fever.

Selection and upkeep of the list follow defined criteria. Key factors include safety profiles, demonstrable clinical benefit, cost-effectiveness, broad indications, stability and shelf life, and reliable manufacturing and supply. National agencies or professional organizations usually maintain the list and review it periodically, adapting to local epidemiology, resistance patterns, and updated clinical guidelines. Generics substitution and streamlined stock management are commonly encouraged to improve access and reduce costs.

Role in the health system: Basismedikamente influence formularies and reimbursement policies, guiding prescribers toward first-line therapies and reducing regional variation in care. By prioritizing affordable medicines, the concept aims to ensure equitable access, support sustainable financing, and simplify procurement for pharmacies and health facilities.

Challenges and considerations: Rigid lists can risk under-treatment if disease patterns shift or if supply chains fail. Ongoing review is necessary to reflect current evidence and public health priorities. Effective implementation requires coordination among policymakers, clinicians, and manufacturers, and should be integrated with broader essential medicines strategies and stewardship programs.